This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human TGF-alpha Quantikine ELISA Kit
catalog :
DTGA00
quantity :
1 Kit
price :
655 USD
citations: 29
Reference
Michalak A, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, Telejko I, et al. miRNAs and Hematological Markers in Non-Alcoholic Fatty Liver Disease-A New Diagnostic Path?. Biomedicines. 2025;13: pubmed publisher
Michalak A, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, Szczygie x142 K, et al. microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis. Biomedicines. 2024;12: pubmed publisher
Vogeley C, Sondermann N, Woeste S, Momin A, Gilardino V, Hartung F, et al. Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR response. Environ Int. 2022;158:106989 pubmed publisher
Kreß J, Jessen C, Marquardt A, Hufnagel A, Meierjohann S. NRF2 Enables EGFR Signaling in Melanoma Cells. Int J Mol Sci. 2021;22: pubmed publisher
Michalak A, Cicho x17c Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W. Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients. Biomed Res Int. 2021;2021:8867985 pubmed publisher
Michalak A, Cichoz Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, et al. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales. World J Gastroenterol. 2020;26:7538-7549 pubmed publisher
Codony Servat J, García Roman S, Molina Vila M, Bertran Alamillo J, Viteri S, D Hondt E, et al. Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells. Transl Oncol. 2021;14:100887 pubmed publisher
Staumont B, Jamakhani M, Costa C, Vandermeers F, Sriramareddy S, Redout xe9 G, et al. TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma. Cancers (Basel). 2020;12: pubmed publisher
Mésange P, Bouygues A, Ferrand N, Sabbah M, Escargueil A, Savina A, et al. Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status. Clin Cancer Res. 2018;24:2548-2558 pubmed publisher
Alvarado D, Ligon G, Lillquist J, Seibel S, Wallweber G, Neumeister V, et al. ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC. PLoS ONE. 2017;12:e0181356 pubmed publisher
Chang S, Linderholm A, Harper R. DUOX-Mediated Signaling Is Not Required for LPS-Induced Neutrophilic Response in the Airways. PLoS ONE. 2015;10:e0131810 pubmed publisher
Yonesaka K, Satoh T, Ueda S, Yoshida T, Takeda M, Shimizu T, et al. Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancer. Anticancer Res. 2015;35:1683-9 pubmed
Zhang Z, Dong Z, Lauxen I, Filho M, Nor J. Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype. Cancer Res. 2014;74:2869-81 pubmed publisher
Tanizaki J, Okamoto I, Okabe T, Sakai K, Tanaka K, Hayashi H, et al. Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer. Clin Cancer Res. 2012;18:6219-26 pubmed publisher
Holterman C, Franovic A, Payette J, Lee S. ETS-1 oncogenic activity mediated by transforming growth factor alpha. Cancer Res. 2010;70:730-40 pubmed publisher
Egloff A, Rothstein M, Seethala R, Siegfried J, Grandis J, Stabile L. Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res. 2009;15:6529-40 pubmed publisher
Kreeger P, Mandhana R, Alford S, Haigis K, Lauffenburger D. RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects. Cancer Res. 2009;69:8191-9 pubmed publisher
Debucquoy A, Haustermans K, Daemen A, Aydin S, Libbrecht L, Gevaert O, et al. Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer. J Clin Oncol. 2009;27:2751-7 pubmed publisher
Han S, Oh D, Im S, Park S, Lee K, Song H, et al. Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. Br J Cancer. 2009;100:298-304 pubmed publisher
Bergin D, Greene C, Sterchi E, Kenna C, Geraghty P, Belaaouaj A, et al. Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. J Biol Chem. 2008;283:31736-44 pubmed publisher
Sasaki T, Nakamura T, Rebhun R, Cheng H, Hale K, Tsan R, et al. Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model. Am J Pathol. 2008;173:205-16 pubmed publisher
Ren W, Korchin B, Zhu Q, Wei C, Dicker A, Heymach J, et al. Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo. Clin Cancer Res. 2008;14:2785-95 pubmed publisher
Le Quement C, Guenon I, Gillon J, Lagente V, Boichot E. MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1076-84 pubmed publisher
Garcia B, Neninger E, de la Torre A, Leonard I, Martínez R, Viada C, et al. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth fa. Clin Cancer Res. 2008;14:840-6 pubmed publisher
Zhu J, Jia X, Xiao G, Kang Y, Partridge N, Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem. 2007;282:26656-64 pubmed
Lemos González Y, Rodriguez Berrocal F, Cordero O, Gomez C, Paez de la Cadena M. Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma. Br J Cancer. 2007;96:1569-78 pubmed
Janes K, Gaudet S, Albeck J, Nielsen U, Lauffenburger D, Sorger P. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell. 2006;124:1225-39 pubmed
Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;175:6177-89 pubmed
Scholl F, Dumesic P, Khavari P. Mek1 alters epidermal growth and differentiation. Cancer Res. 2004;64:6035-40 pubmed
product information
master code :
DTGA00
SKU :
DTGA00
product name :
Human TGF-alpha Quantikine ELISA Kit
unit size :
1 Kit
description :
The Human TGF-alpha Quantikine ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human TGF-alpha in cell culture supernates (50 ul), serum (50 ul), edta plasma (50 ul), heparin plasma (50 ul), human milk (50 ul).
target :
TGF-alpha
category :
ELISAs
species :
Human
specificity :
Natural and recombinant human TGF-alpha
gene symbol :
TGFA
kit type :
Solid Phase Sandwich ELISA
assay length :
4.5 hours
elisaSampleTypes :
Cell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL), Human Milk (50 uL)
elisaSensitivity :
7.1 pg/mL
elisaRange :
15.60 - 1000 pg/mL
top caption :
Human TGF-alpha ELISA Standard Curve
applications :
ELISA
USD :
655 USD
product details :
The Quantikine Human TGF-alpha Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human TGF-alpha in cell culture supernates, serum, plasma, and human milk. It contains E. coli -expressed recombinant human TGF-alpha and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human TGF-alpha showed linear curves that were parallel to the standard curves obtained using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring human TGF-alpha.
alt names :
protransforming growth factor alpha, TFGA, TGFA, TGFalpha, transforming growth factor, alpha, transforming growth factor-alpha
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.